Skip to main content
. 2020 Mar 2;39(17):3541–3554. doi: 10.1038/s41388-020-1237-0

Fig. 5. The clinical significance of the number of tumor-infiltrating CD8-positive lymphocytes and PD-L1 expression on tumor cells in 24 MCT-SCC/ASCs.

Fig. 5

a Immunohistochemical staining for CD8 in 24 MCT-SCC/ASCs. b Kaplan–Meier estimates of progression-free survival and overall survival between the CD8-high and -low groups. c Immunohistochemical staining for PD-L1 in 24 MCT-SCC/ASCs. d Kaplan–Meier estimates of progression-free survival and overall survival between PD-L1-positive and PD-L1-negative patients.